a public good project by the
Synthesis
Company
of California

© 2026

Judy E. Garber | doi.page

0 works0 citations0 h-index

Judy E. Garber

Harvard University(US)Massachusetts General Hospital(US)

Publications by Year

Research Areas

BRCA gene mutations in cancer, Cancer Genomics and Diagnostics, DNA Repair Mechanisms, Genetic factors in colorectal cancer, Nutrition, Genetics, and Disease

Most-Cited Works

→ The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer(1993)2,887 cited
→ Mutational Processes Molding the Genomes of 21 Breast Cancers(2012)1,984 cited
→ Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial(2010)1,629 cited
→ Adjuvant Olaparib for Patients with BRCA1 - or BRCA2 -Mutated Breast Cancer(2021)1,581 cited
→ Prophylactic Oophorectomy in Carriers ofBRCA1orBRCA2Mutations(2002)1,459 cited
→ Molecular Definition of Breast Tumor Heterogeneity(2007)1,352 cited

→ De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017(2017)

1,245 cited

→ Bilateral Prophylactic Mastectomy Reduces Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: The PROSE Study Group(2004)1,137 cited

→ Homologous Recombination Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer(2016)1,128 cited

→ Efficacy of Neoadjuvant Cisplatin in Triple-Negative Breast Cancer(2010)977 cited